Ridge Biotechnologies raises additional capital, bringing its total to approximately $38M. The upsized seed round was led by Dimension Capital, alongside Sutter Hill Ventures and Overlap Holdings.
Amount Raised
$38 Million
Round Type
Seed
Palo AltoBiotechnologyHealth CareArtificial IntelligenceInvestors
Description
Ridge Biotechnologies, a biotechnology company focused on enzyme and conditionally-activated drug design, announced additional investment as demand grows for its AI-designed bioconjugate therapeutics. This funding brings their total capital raised to approximately $38M. The latest round was anchored by Dimension Capital and included support from founding investors.
Quick answer
Ridge Biotechnologies raised $38 Million in a Seed round, dated September 9, 2026. Investors: Sutter Hill Ventures, Overlap Holdings and Dimension Capital. Ridge Biotechnologies is based in Palo Alto, California, United States.
- How much did Ridge Biotechnologies raise?
- Ridge Biotechnologies raised $38 Million in a Seed round on September 9, 2026.
- Who invested in Ridge Biotechnologies?
- Sutter Hill Ventures, Overlap Holdings and Dimension Capital are named as investors in this round.
- What does Ridge Biotechnologies do?
- Ridge Biotechnologies is a pioneering company focused on AI-enabled precision enzyme and targeted drug design.
- Where is Ridge Biotechnologies based and how big is it?
- Ridge Biotechnologies is based in Palo Alto, California, United States. Fundz records about 14 employees.
- Who are the decision-makers at Ridge Biotechnologies?
- Fundz holds 1 contact at Ridge Biotechnologies, including the VP of ADCs. Names and contact details are shown to Fundz members.
Source: Fundz verified event record.
Who else raised in Biotechnology and Health Care around the same time
Companies in the same sectors as Ridge Biotechnologies that raised within 45 days of this round, from Fundz verified event records.
- Pathos AI raised $237M (Series E) on October 23, 2026.
- BioStack raised $9.5M (Seed) on October 22, 2026.
- Coherence Neuro raised $45M (Series A) on October 22, 2026.
- XRlabs raised $8.4M (Seed) on October 19, 2026.
- Sunlight AI raised $17M (Seed) on October 19, 2026.
- Recursion Pharmaceuticals raised $200M (Post-IPO Equity) on October 15, 2026.
Who to call at Ridge Biotechnologies, and when
A new round usually means Ridge Biotechnologies is about to hire and buy. The teams that reach out first get the meeting.
- An alert the day Ridge Biotechnologies raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at Ridge Biotechnologies, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at Ridge Biotechnologies. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment Ridge Biotechnologies raises, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Related People
Ridge Biotechnologies raised. Fundz records a round at a median of 3.6 minutes from the SEC filing, with the decision-maker attached.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.